C

CTC Bio Inc
KOSDAQ:060590

Watchlist Manager
CTC Bio Inc
KOSDAQ:060590
Watchlist
Price: 4 715 KRW 1.95% Market Closed
Market Cap: 114B KRW

Net Margin
CTC Bio Inc

-0.6%
Current
-4%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-0.6%
=
Net Income
-852.3m
/
Revenue
141.4B

Net Margin Across Competitors

Country Company Market Cap Net
Margin
KR
CTC Bio Inc
KOSDAQ:060590
112.7B KRW
-1%
US
Eli Lilly and Co
NYSE:LLY
1T USD
31%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
-4%
US
Johnson & Johnson
NYSE:JNJ
498.9B USD
27%
CH
Roche Holding AG
SIX:ROG
261.4B CHF
15%
UK
AstraZeneca PLC
LSE:AZN
210.8B GBP
16%
CH
Novartis AG
SIX:NOVN
210.3B CHF
26%
US
Merck & Co Inc
NYSE:MRK
264.8B USD
30%
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK
33%
IE
Endo International PLC
LSE:0Y5F
213.9B USD
-126%
US
Pfizer Inc
NYSE:PFE
143.2B USD
16%
No Stocks Found

CTC Bio Inc
Glance View

Market Cap
112.7B KRW
Industry
Pharmaceuticals

CTC Bio, Inc. engages in the manufacture of pharmaceuticals, functional food and animal health products. The company is headquartered in Hongcheon, Gangwon-Do. The company went IPO on 2002-02-21. The company pharmaceuticals include anticancer agents, antibiotics, bone injury treatments, antiulcer agents, blood flow stimulants and others. Its veterinary drugs include vaccines, antibiotics, immune enhancers, enzymes, organic acid, avian influenza-related agents and others. Its animal feed supplements include pigments, kapok seed meal, sesame meal and others. Its functional food business includes the development and manufacture of enzymes, lactobacillus and related products mainly used in dairy products. The company also involves in the development of pharmaceutical manufacturing technology and know-how. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
4 016.77 KRW
Overvaluation 15%
Intrinsic Value
Price
C
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-0.6%
=
Net Income
-852.3m
/
Revenue
141.4B
What is the Net Margin of CTC Bio Inc?

Based on CTC Bio Inc's most recent financial statements, the company has Net Margin of -0.6%.

Back to Top